Table 4.

Corticosteroid use in all patients

Disease status: CRP requirement (mg/dL): n:	Idiopathic			PPS		Total
	Active* >1 12	Active† ≤1 3	CS-dep‡ N/A 6	Active§ >1 1	CS-dep¶ N/A 3	All*†‡§¶ N/A 25
Baseline
Patients on prednisone, n	4	2	6	0	3	15
Mean dose (mg/day)	8.4	40.0	8.9	0	7.7	12.7
Median dose	10.0	40.0	4.5	0	5.0	8.0
Min	1.0	30.0	2.5	0	3.0	1.0
Max	12.5	50.0	30.0	0	15.0	50.0
SD	5.06	14.14	10.49	NA	6.43	13.72
Corticosteroid changed during TP and EP combined in patients who completed EP
Prednisone dose decreased	0/3	1/2 (50.0)	1/5 (20.0)	0/0	0/3	2/13 (15.4)
Prednisone stopped	3/3 (100.0)	1/2 (50.0)	4/5 (80.0)	0/0	3/3 (100.0)	11/13 (84.6)
Prednisone dose increased	0/3	0/2	0/5	0/0	0/3	0/13
Prednisone initiated	0/11	0/3	0/5	0/1	0/3	0/23

*Part 1.

†Part 2.

‡Part 3.

§Part 4.

¶Part 5.

CRP, C reactive protein; CS-dep, corticosteroid dependent; EP, extension period; PPS, postpericardiotomy syndrome; TP, treatment period.